Although the therapeutic effects of FGF21 on the latter two vasculopathies have been well studied previously17,18, it remains unclear whether FGF21 ameliorates impaired endothelial function in metabolic diseases such as T2D. This evidence concerns the gene FGF21 and metabolic disease.